{"Abstract": "The field of drug discovery has witnessed significant advancements with the integration of ultralarge and structure-based virtual screening approaches. These methodologies leverage vast chemical libraries and sophisticated computational techniques to identify potential drug candidates with enhanced precision and efficiency. Recent developments have focused on the application of molecular docking and free energy simulations, which are now accelerated by GPU technology, allowing for the rapid processing of extensive datasets. Additionally, the incorporation of machine learning and deep learning algorithms has further refined the predictive accuracy of these screenings, enabling the identification of novel compounds with desirable pharmacological properties. This review highlights the transformative impact of these technologies on the drug discovery pipeline, emphasizing their role in reducing the time and cost associated with traditional experimental methods. By integrating these cutting-edge approaches, researchers can now explore chemical space more comprehensively, paving the way for the discovery of new therapeutics with improved efficacy and safety profiles."}